FindTrial
Sign In

To find a tumor marker in colorectal cancer where the conventional marker fails and its impact on short term patient survival

Study on correlation between CA 19-9 and colorectal carcinoma with normal or near normal CEA and its impact on patient survival

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036543
Enrollment
40
Registered
2021-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified

Interventions

None listed

Sponsors

Medical College Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All newly diagnosed patients with colorectal carcinoma

Exclusion criteria

Exclusion criteria: 1.Patients with other cancer 2. Patients with pancreatitis, Inflammatory Bowel Disease, Cirrhosis of liver 3.Patients already on systemic chemotherapy or Radiotherapy or concurrent chemoradiation

Design outcomes

Primary

MeasureTime frame
There may be a correlation between serum level of CA 19.9 in colorectal carcinoma with normal or near normal CEA level for early detection and its association with disease prognosis in terms of short term disease free survival and overall survivalTimepoint: 1 year—

Secondary

MeasureTime frame
Elevated serum CA 19.9 level is associated with early age at presentation, higher disease staging and poor histologic grading 2. Elevated serum CA 19.9 level at presenation is also associated with poor prognosisTimepoint: 6 months follow up—

Countries

India

Contacts

Public ContactAvisikta Mallick

MEDICAL COLLEGE, KOLKATA

drarkanatmed1997@gmail.com9830041886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026